- Home
- TLX vs POR Comparison
TLX vs POR Comparison
Compare TLX & POR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLX
- POR
- Stock Information
- Founded
- TLX 2015
- POR 1889
- Country
- TLX Australia
- POR United States
- Employees
- TLX N/A
- POR N/A
- Industry
- TLX Biotechnology: Pharmaceutical Preparations
- POR Electric Utilities: Central
- Sector
- TLX Health Care
- POR Utilities
- Exchange
- TLX Nasdaq
- POR Nasdaq
- Market Cap
- TLX 5.8B
- POR 4.9B
- IPO Year
- TLX N/A
- POR N/A
- Fundamental
- Price
- TLX $19.50
- POR $44.36
- Analyst Decision
- TLX Strong Buy
- POR Hold
- Analyst Count
- TLX 1
- POR 10
- Target Price
- TLX $22.00
- POR $47.00
- AVG Volume (30 Days)
- TLX 18.8K
- POR 1.1M
- Earning Date
- TLX 01-01-0001
- POR 02-14-2025
- Dividend Yield
- TLX N/A
- POR 4.51%
- EPS Growth
- TLX N/A
- POR 29.18
- EPS
- TLX 0.09
- POR 3.01
- Revenue
- TLX $484,687,790.00
- POR $3,440,000,000.00
- Revenue This Year
- TLX N/A
- POR N/A
- Revenue Next Year
- TLX N/A
- POR $4.59
- P/E Ratio
- TLX $209.40
- POR $14.74
- Revenue Growth
- TLX 80.92
- POR 17.69
- 52 Week Low
- TLX $14.01
- POR $39.49
- 52 Week High
- TLX $20.00
- POR $49.85
- Technical
- Relative Strength Index (RSI)
- TLX N/A
- POR 67.31
- Support Level
- TLX N/A
- POR $41.32
- Resistance Level
- TLX N/A
- POR $41.94
- Average True Range (ATR)
- TLX 0.00
- POR 0.81
- MACD
- TLX 0.00
- POR 0.42
- Stochastic Oscillator
- TLX 0.00
- POR 94.88
About TLX Telix Pharmaceuticals Limited American Depositary Shares
Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.
About POR Portland General Electric Co
Portland General Electric is a regulated electric utility providing generation, transmission, and distribution services in a service territory that includes about half of all Oregon residents and two thirds of the state's business activity. The company owns (wholly or through joint ventures) 3.5 gigawatts of gas, coal, wind, and hydro generation.